ZSTK · ZeroStack Corp. Common Stock
View on chartInsiders & Stakes
| Daniel Reis-Faria CEO | ▼ Sell | Other | 5,954,743 Shares held | 7/20/2026 | View profile |
| Michael Heinrich Executive Chairman | ▲ Buy | Open Market | 4,608,575 Shares held | 7/20/2026 | View profile |
| Juan Carlos Gomez Roa Director | ▲ Buy | Grant | 2,042,509 Shares held | 3/17/2023 | View profile |
| Clifford Starke CEO | ▲ Buy | Grant | 906,846 Shares held | 12/15/2024 | View profile |
| Cohen, Matthew S. General Counsel | ▼ Sell | Tax Withholding | 329,610 Shares held | 5/18/2023 | View profile |
| Sammy Dorf Executive Chairman | ▲ Buy | Grant | 250,000 Shares held | 12/15/2024 | View profile |
| Dany Vaiman CFO | ▲ Buy | Grant | 170,850 Shares held | 11/15/2023 | View profile |
| Marc Mastronardi Director | ▲ Buy | Grant | 160,000 Shares held | 3/17/2023 | View profile |
| Beverley Richardson Director | ▲ Buy | Grant | 150,000 Shares held | 3/17/2023 | View profile |
| John Timothy Leslie Director | ▲ Buy | Grant | 138,574 Shares held | 3/17/2023 | View profile |
| Edward Woo | ▲ Buy | Grant | 134,698 Shares held | 12/15/2024 | View profile |
| Kevin Taylor Chairman | ▲ Buy | Grant | 124,186 Shares held | 11/15/2023 | View profile |
| Brandon Konigsberg Director | ▲ Buy | Grant | 100,000 Shares held | 3/17/2023 | View profile |
| Thomas Solomon | ▲ Buy | Grant | 35,766 Shares held | 11/15/2023 | View profile |
| Harold Wolkin | ▲ Buy | Open Market | 25,000 Shares held | 9/6/2024 | View profile |
| Hussein Rakine Chief Executive Officer | ▼ Sell | Other | 2,500 Shares held | 6/25/2023 | View profile |
| Rong Rudy President | ▼ Sell | Open Market | 0 Shares held | 8/19/2026 | View profile |
Transaction History
| Rong Rudy | ▼ Sell | Open Market | 1,000 | $8K | 8/19/2026 |
| Michael Heinrich | ▲ Buy | Open Market | 4,608,575 | $3.5M | 7/20/2026 |
| Daniel Reis-Faria | ▼ Sell | Other | 5,954,743 | $595 | 7/20/2026 |
| Edward Woo | ▲ Buy | Grant | 50,000 | — | 12/15/2024 |
| Clifford Starke | ▲ Buy | Grant | 900,000 | — | 12/15/2024 |
| Sammy Dorf | ▲ Buy | Grant | 250,000 | — | 12/15/2024 |
| Clifford Starke | ▲ Buy | Open Market | 6,795 | $6K | 9/13/2024 |
| Harold Wolkin | ▲ Buy | Open Market | 5,000 | $5K | 9/6/2024 |
| Harold Wolkin | ▲ Buy | Open Market | 15,000 | $15K | 9/6/2024 |
| Harold Wolkin | ▲ Buy | Open Market | 5,000 | $5K | 9/6/2024 |
| Clifford Starke | ▲ Buy | Open Market | 51 | $48 | 9/5/2024 |
| Clifford Starke | ▲ Buy | Open Market | 526,315 | $1000K | 4/8/2024 |
| Dany Vaiman | ▲ Buy | Grant | 149,024 | — | 11/15/2023 |
| Thomas Solomon | ▲ Buy | Grant | 35,766 | — | 11/15/2023 |
| Edward Woo | ▲ Buy | Grant | 74,512 | — | 11/15/2023 |
| Kevin Taylor | ▲ Buy | Grant | 124,186 | — | 11/15/2023 |
| Clifford Starke | ▲ Buy | Grant | 327,851 | — | 11/15/2023 |
| Hussein Rakine | ▼ Sell | Other | 82,100 | $0 | 6/25/2023 |
| Cohen, Matthew S. | ▼ Sell | Tax Withholding | 90,146 | $22K | 5/18/2023 |
| Hussein Rakine | ▲ Buy | Grant | 1,200,000 | $0 | 4/16/2023 |
| John Timothy Leslie | ▲ Buy | Grant | 125,000 | $0 | 3/17/2023 |
| Beverley Richardson | ▲ Buy | Grant | 150,000 | $0 | 3/17/2023 |
| Marc Mastronardi | ▲ Buy | Grant | 150,000 | $0 | 3/17/2023 |
| Juan Carlos Gomez Roa | ▲ Buy | Grant | 150,000 | $0 | 3/17/2023 |
| Brandon Konigsberg | ▲ Buy | Grant | 100,000 | $0 | 3/17/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ZeroStack Corp. noted among health‑care stocks moving in pre‑market
ZeroStack Corp. appeared in a Benzinga list of health‑care stocks that showed price movement in Friday’s pre‑market session. The mention highlights short‑term interest in the stock ahead of regular trading. The stock is currently near its $1.70 support level, with an RSI around the mid‑40s.
ZeroStack Corp. noted among health‑care stocks moving in pre‑market. ZeroStack Corp. appeared in a Benzinga list of health‑care stocks that showed price movement in Friday’s pre‑market session. The mention highlights short‑term interest in the stock ahead of regular trading. The stock is currently near its $1.70 support level, with an RSI around the mid‑40s.